The government on Tuesday cancelled the licenses of 18 pharma companies for manufacturing of spurious medicines following the inspection by the Drugs Controller General of India (DCGI) on 76 companies across 20 States, official sources informed.
The sources further said that a huge crackdown is underway on several pharma companies across the country related to the manufacturing of spurious medicines.
(More to follow…)
ALSO READ | Opposition parties likely to bring no-confidence motion against Lok Sabha Speaker Om Birla: Report